Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil
Charles S. Grob, Dennis J. Mckenna, James C. Callaway, Glacus S. Brito, Edison S. Neves, Guilherme Oberlaender, Oswaldo L. Saide, Elizeu Labigalini, Cristiane Tacla, Cláudio Torres de Miranda, Rick J. Strassman, Kyle B. Boone
The Journal of Nervous and Mental Disease February 1, 1996 DOI: 10.1097/00005053-199602000-00004 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort with matched controls Peer reviewed |
|---|---|
| Sample size | 30 |
| Population | Long-term members of a syncretic church that uses hoasca as a psychoactive sacrament and matched controls with no prior hoasca ingestion |
| Intervention | hoasca (ayahuasca) |
| Topics | Ayahuasca Psilocybin |
| Keywords | Hallucinogen Psychopathology Context archaeology Personality Clinical psychology Psychotherapist Anthropology |
| Citations | 333 |
| Key findings | Remission of psychopathology followed the initiation of hoasca use, with no evidence of personality or cognitive deterioration and high functional status among long-term users. |
Abstract
A multinational, collaborative, biomedical investigation of the effects of hoasca (ayahuasca), a potent concoction of plant hallucinogens, was conducted in the Brazilian Amazon during the summer of 1993. This report describes the psychological assessment of 15 long-term members of a syncretic church that utilizes hoasca as a legal, psychoactive sacrament as well as 15 matched controls with no prior history of hoasca ingestion. Measures administered to both groups included structured psychiatric diagnostic interviews, personality testing, and neuropsychological evaluation. Phenomenological assessment of the altered state experience as well as semistructured and open-ended life story interviews were conducted with the long-term use hoasca group, but not the hoasca-naive control group. Salient findings included the remission of psychopathology following the initiation of hoasca use along with no evidence of personality or cognitive deterioration. Overall assessment revealed high functional status. Implications of this unusual phenomenon and need for further investigation are discussed.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: Ayahuasca Supports
Long-term hoasca users showed remission of psychopathology following initiation of use, no evidence of personality or cognitive deterioration, and high functional status.
Synthesized
Comparable studies
Other observational and cohort studies on ayahuasca, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report Patients with a depressive disorder | 2015 | Observational study | |
| The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network Experienced subjects | 2015 | Observational cohort | n = 10 |
| Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population | 2013 | Observational study | |
| Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study Regular ayahuasca users and active controls in non-ayahuasca religions | 2012 | Observational cohort | n = 242 |
| Assessment of addiction severity among ritual users of ayahuasca Regular ayahuasca users (jungle-based and urban-based) and matched controls | 2010 | Observational cohort | n = 127 |
Citations in the library
Cited by 239
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness Journal of Psychopharmacology September 28, 2011
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Current Drug Abuse Reviews June 1, 2013
and 234 more in the library
Cites 4
- Dose-Response Study of N,N-Dimethyltryptamine in Humans Archives of General Psychiatry February 1, 1994
- Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Journal of Ethnopharmacology April 1, 1984
- Adolescent Drug Use in Cross-Cultural Perspective Journal of Drug Issues 1992
- Shamans, Sacraments, and Psychiatrists Journal of Psychoactive Drugs 1989